[HTML][HTML] LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
L Zhu, A Wang, M Gao, X Duan, Z Li - Cancer cell international, 2020 - Springer
Background Accumulating studies showed that long noncoding RNAs (lncRNAs) played
vital roles in cancer progression. LncRNA MIR4435-2HG was proved to act as an oncogene …
vital roles in cancer progression. LncRNA MIR4435-2HG was proved to act as an oncogene …
[HTML][HTML] LINC00460 accelerates progression of ovarian cancer by activating transcriptional factor ZNF703
X Wang, X Gan, C Liu, W Zhang - Oncology Letters, 2020 - spandidos-publications.com
Potential function of LINC00460 in the progression of ovarian cancer (OC) and its underlying
mechanism were studied. LINC00460 level in OC tissues and normal ovarian tissues was …
mechanism were studied. LINC00460 level in OC tissues and normal ovarian tissues was …
[HTML][HTML] Down-regulation of ZNF252P-AS1 alleviates ovarian cancer progression by binding miR-324-3p to downregulate LY6K
L Geng, Z Wang, Y Tian - Journal of Ovarian Research, 2022 - Springer
Background Ovarian cancer is a common gynecological malignant disease in women. Our
work aimed to study the specific functions of ZNF252P antisense RNA 1 (ZNF252P-AS1) in …
work aimed to study the specific functions of ZNF252P antisense RNA 1 (ZNF252P-AS1) in …
[HTML][HTML] ncRNA-mediated low expression of P2RY14 correlates with poor prognosis and tumor immune infiltration in ovarian carcinoma
C Shu, L Liu, X Chen, J Xue, J Fei, J Wang… - Annals of …, 2023 - ncbi.nlm.nih.gov
Background Ovarian cancer (OV) has been puzzling clinicians because of its poor
prognosis. More and more evidence show that the G protein coupled receptor P2RY14 plays …
prognosis. More and more evidence show that the G protein coupled receptor P2RY14 plays …
Identification of novel genes and pathways of Ovarian Cancer using a Comprehensive Bioinformatic Framework
H Rashid, A Ullah, S Ahmad, SM Aljahdali… - Applied Biochemistry …, 2023 - Springer
Ovarian cancer (OC) is a significant contributor to gynecological cancer-related deaths
worldwide, with a high mortality rate. Despite several advances in understanding the …
worldwide, with a high mortality rate. Despite several advances in understanding the …
[HTML][HTML] Diagnostic value of KLK6 as an ovarian cancer biomarker: A meta-analysis
F Yang, ZD Hu, Y Chen, CJ Hu - Biomedical reports, 2016 - spandidos-publications.com
Abstract Kallikrein-related peptidase 6 (KLK6) is a new potential serum biomarker of ovarian
cancer. The aim of the present study was to assess the diagnostic value of KLK6 …
cancer. The aim of the present study was to assess the diagnostic value of KLK6 …
MiR-495-3p and miR-143-3p co-target CDK1 to inhibit the development of cervical cancer
J Tang, H Pan, W Wang, C Qi, C Gu, A Shang… - Clinical and Translational …, 2021 - Springer
Purpose The GEO database and KEGG database-based analyses identified the differential
expression of cyclin-dependent kinase 1 (CDK1) in cervical cancer and its involvement in …
expression of cyclin-dependent kinase 1 (CDK1) in cervical cancer and its involvement in …
Overexpression of miR-493-3p suppresses ovarian cancer cell proliferation, migration and invasion through downregulating DPY30
Q Liu, H Yang, H Hua - Reproductive biology, 2022 - Elsevier
Accumulating evidence has verified that the aberrant expression level of miR-493− 3p is
often associated with the occurrence of numerous cancers. Nevertheless, the expression …
often associated with the occurrence of numerous cancers. Nevertheless, the expression …
[PDF][PDF] Bioinformatics analysis and experiments identify CD74 as a potential immune target in ovarian carcinoma
Y Zhang, X Zhang, L Zhang, Y Zhao… - Arch. Med …, 2022 - archivesofmedicalscience.com
Introduction: Ovarian carcinoma (OC) is one of the most common malignancies in women
worldwide. Immune checkpoint inhibitors are routinely used to treat OC, but with little clinical …
worldwide. Immune checkpoint inhibitors are routinely used to treat OC, but with little clinical …
[HTML][HTML] MiR‑124 inhibits invasion and induces apoptosis of ovarian cancer cells by targeting programmed cell death 6
L Yuan, S Li, Q Zhou, D Wang, D Zou… - Oncology …, 2017 - spandidos-publications.com
Epithelial ovarian cancer remains the most common type of malignant tumor of the female
reproductive system worldwide. Routine surgery and chemotherapy are the best treatments …
reproductive system worldwide. Routine surgery and chemotherapy are the best treatments …